November 2017

Editorial Board
Published in issue: November 2017
ii

Editorials

Learning’s from the Editors Desk – 2017
• Scott C. Bell,
• Carlo Castellani,
• Patrick A. Flume
Published in issue: November 2017
p645-646
New Comorbidities in the Changing Face of Cystic Fibrosis Care
• Michael Bonk,
• Michael M. Rey,
• Denis Hadjiliadis
Published in issue: November 2017
p647-648
Exercise assessment and training in cystic fibrosis: Can less achieve more?
• Narelle S. Cox,
• Anne E. Holland
Published online: October 12, 2017
p649-650

News article

News
• Diana Bilton
Published in issue: November 2017
p651-652

Reviews

Bicarbonate in cystic fibrosis
• Karl Kunzelmann,
• Rainer Schreiber,
• Hans Beat Hadorn
Published online: July 18, 2017
p653-662

The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways
• Stephanie Trend,
• Angela M. Fonceca,
• William G. Ditcham,
• Anthony Kicic,
• AREST CF
Published online: July 15, 2017
p663-670

CFTR/Basic Science

Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice
• Jeff R. Crosby,
• Chenguang Zhao,
• Chong Jiang,
• ...
• Daniela Rotin,
• Shuling Guo,
• Brett P. Monia
Published online: May 20, 2017
p671-680

Microbiology

Risk factors for persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis
• Mark T. Jennings,
• Elliot C. Dasenbrook,
• Noah Lechtzin,
• Michael P. Boyle,
• Christian A. Merlo
Published online: April 23, 2017
p681-686

Epidemiology/Models of Care

Pregnancy among cystic fibrosis women in the era of CFTR modulators
• Sonya L. Heltshe,
• Emily M. Godfrey,
• Tatiana Josephy,
• Moira L. Aitken,
• Jennifer L. Taylor-Cousar
Published online: February 10, 2017
p687-694

A treatment evaluator tool to monitor the real-world effectiveness of inhaled aztreonam lysine in cystic fibrosis
• Barry J Plant,
• Damian G Downey,
• Joe A Eustace,
• ...
• Daniel G Peckham,
• R. Ian Ketchell,
• Diana Bilton
Published online: April 06, 2017
p695-701

A 3-year prognostic score for adults with cystic fibrosis
• L. Nkam,
• J. Lambert,
• A. Latouche,
• G. Bellis,
• PR. Burgel,
• M.N. Hocine
Published online: March 19, 2017
p702-708

Clinical Trials

Real-life acute lung function changes after lumacaftor/ivacaftor first administration in pediatric patients with cystic fibrosis
• Aurélie Labaste,
• Camille Ohlmann,
• Catherine Mainguy,
• ...
• Marie Perceval,
• Laurianne Coutier,
• Philippe Reix
Published online: May 18, 2017
p709-712

Pulmonology

Effect of posture on lung ventilation distribution and associations with structure in children with cystic fibrosis
• Kathryn A. Ramsey,
• Caroline McGirr,
• Stephen M. Stick,
• Graham L. Hall,
• Shannon J. Simpson
• on behalf of AREST CF
Published online: February 07, 2017
p713-718

What keeps children with cystic fibrosis awake at night?
• Moya Vandeleur,
• Lisa M. Walter,
• David S. Armstrong,
• Philip Robinson,
• Gillian M. Nixon,
• Rosemary S.C. Horne
Published online: May 04, 2017
p719-726

Transplantation

Increased risk of PTLD in lung transplant recipients with cystic fibrosis
• Erin M. Lowery,
• William Adams,
• Shellee A. Grim,
• Nina M. Clark,
• Leah Edwards,
• Jennifer E. Layden
Published online: April 27, 2017
p727-734

Tracheal diverticula in advanced cystic fibrosis: Prevalence, features, and outcomes after lung transplantation
• Siddhartha G. Kapnadak,
• Gregory A. Kicska,
• Kathleen J. Ramos,
• ...
• Michael S. Mulligan,
• Christopher H. Goss,
• Moira L. Aitken
Published online: July 28, 2017
p735-743

Exercise

The 1-min sit-to-stand test in cystic fibrosis — Insights into cardiorespiratory responses
• Thomas Radtke,
• Helge Hebestreit,
• Milo A. Puhan,
• Susi Kriemler
Published online: February 07, 2017
p744-751

A single bout of maximal exercise improves lung function in patients with cystic fibrosis
• Matthew A. Tucker,
• Reva Crandall,
• Nichole Seigler,
• ...
• Caralee Forseen,
• Jeffrey Thomas,
• Ryan A. Harris
Published online: June 24, 2017
p752-758

Gastroenterology/Hepatology

Increased prevalence of colonic adenomas in patients with cystic fibrosis
• Mehdi Hegagi,
• Shawn D. Aaron,
• Paul James,
• Rakesh Goel,
• Avijit Chatterjee
Published online: July 22, 2017
p759-762

Bile salt stimulated lipase: Inhibition by phospholipids and relief by phospholipase A₂
• Elena Venuti,
• Dmitry Shishmarev,
• Philip W. Kuchel,
• Shoma Dutt,
• Caron S. Blumenthal,
• Kevin J. Gaskin
Published online: July 21, 2017
p763-770

Online Only Publications

Comment on data sparsity - Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study
• Erfan Ayubi,
• Jamal Hallajzadeh,
• Saeid Safiri
Published online: July 24, 2017
e19-e20

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study; response to comments
• H.L. Barr,
• N. Halliday,
• D.A. Barrett,
• ...
• A.J. Knox,
• M. Cámara,
• A.W. Fogarty
Published online: October 24, 2017
e21

Validation of multiple breath washout devices
• Lena Raaijmakers,
• Renee Jensen,
• Sanja Stanojevic,
• Felix Ratjen
Published online: February 07, 2017
e22-e23

Corrigendum to “Does current reporting of lung function by the UK cystic fibrosis registry allow a fair comparison of adult centres?” [J Cyst Fibros (2017) 585–591]
• J.A. Nightingale,
• C. Osmond
Published online: October 12, 2017
e24

Corrigendum to “WS04.1 The effect of Orkambi® on exercise capacity and muscle strength” [J Cyst Fibros, volume 16, supplement 1, June 2017, pages S6–S7]
• R. Buckley,
• C.M. Reilly,
• S. Kelly,
• ...
• S. Carter,
• C.G. Gallagher,
• E.F. McKone
Published online: August 18, 2017
e25